Merck KGaA's 1Q net profit jumps to €191.4 million

Tue, 04/27/2010 - 11:18pm
The Associated Press

The demand for the liquid crystals used in flat-screen televisions and computer monitors has helped push first-quarter net profit at Merck KGaA more than three times higher.

The German drug and chemical maker based in Darmstadt said Wednesday that it had a net profit of €191.4 million ($254.4 million) in the first quarter of this year, a big increase from the €56.7 million it earned in the first three months of 2009.

The jump came as revenues at the company, which makes the cancer drug Erbitux and multiple sclerosis treatment Rebif, rose nearly 13 percent to nearly €2.1 billion in the January-March period compared with nearly €1.9 billion a year earlier.


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.